hasDosingRegimen
P37218
predicate
Indicates that an entity is associated with a specific dosing regimen, defining how and when a dose is to be administered.
All labels observed (9)
| Label | Occurrences |
|---|---|
| dosingRegimen | 5 |
| dosingSchedule | 4 |
| hasDosingSchedule | 4 |
| hasDosingRegimen canonical | 2 |
| hasInitialDosing | 2 |
| hasStandardDose | 2 |
| hasTreatmentFrequency | 2 |
| hasUsualAdultDoseForALS | 1 |
| initialDosingRegimen | 1 |
Description generation (PDg)
The one-sentence description above was generated by prompting gpt-5.1 with the predicate name and this instruction.
Instruction
Given a predicate that represents a relationship or action between entities, generate a one-sentence description explaining its meaning. # Instructions Focus on describing the relationship, not the entities themselves. # Response Format Begin the description with \' Indicates...\'
Input
Predicate: hasDosingRegimen
Generated description
Indicates that an entity is associated with a specific dosing regimen, defining how and when a dose is to be administered.
Sample triples (23)
| Subject | Object |
|---|---|
| Remicade | induction and maintenance ⓘ |
| Stelara | weight-based intravenous induction for Crohn’s disease via predicate surface "hasInitialDosing" ⓘ |
| Stelara | weight-based intravenous induction for ulcerative colitis via predicate surface "hasInitialDosing" ⓘ |
| BCG vaccine | single dose at birth in high-burden countries via predicate surface "dosingSchedule" ⓘ |
| REGN-EB3 | single-course intravenous administration via predicate surface "dosingRegimen" ⓘ |
| onasemnogene abeparvovec | single-dose treatment via predicate surface "dosingRegimen" ⓘ |
|
riluzole
surface form:
Riluzole
|
50 mg twice daily via predicate surface "hasUsualAdultDoseForALS" ⓘ |
| Waylivra | more frequent injections during loading phase via predicate surface "initialDosingRegimen" ⓘ |
| Decision to provide ivermectin (Mectizan) free of charge for river blindness | annual treatment via predicate surface "hasTreatmentFrequency" ⓘ |
| Decision to provide ivermectin (Mectizan) free of charge for river blindness | biannual treatment in some settings via predicate surface "hasTreatmentFrequency" ⓘ |
| Ibrance | 21 days on treatment followed by 7 days off via predicate surface "hasDosingSchedule" ⓘ |
| Fasenra | initially every 4 weeks for the first 3 doses via predicate surface "dosingRegimen" ⓘ |
| Fasenra | then every 8 weeks via predicate surface "dosingRegimen" ⓘ |
| Teglutik | twice daily via predicate surface "dosingSchedule" ⓘ |
| LOXO-305 | once-daily via predicate surface "dosingSchedule" ⓘ |
| BNT162b2 | two-dose primary series via predicate surface "hasDosingSchedule" ⓘ |
| avelumab | every 2 weeks in many indications via predicate surface "dosingSchedule" ⓘ |
| nivolumab | weight-based or fixed-dose intravenous infusion every 2 to 4 weeks via predicate surface "dosingRegimen" ⓘ |
|
ebastine
surface form:
Ebastine
|
10 mg once daily for allergic rhinitis in adults via predicate surface "hasStandardDose" ⓘ |
|
ebastine
surface form:
Ebastine
|
10–20 mg once daily for chronic urticaria in adults via predicate surface "hasStandardDose" ⓘ |
| pomalidomide | 21 days on, 7 days off per 28-day cycle via predicate surface "hasDosingSchedule" ⓘ |
| Teprotumumab | intravenous infusion every 3 weeks for 8 doses ⓘ |
| neratinib | once daily via predicate surface "hasDosingSchedule" ⓘ |